Nowigence (OTCQB: NOWG) is the software-as-a-service (“SaaS”) technology firm behind Pluaris(TM), a comprehensive and turnkey AI knowledge engine. The company announced yesterday that its common stock commenced trading on the OTCQB Venture Market, the mid-tier OTC equity market, which lists primarily early-stage and developing companies in the U.S. and international markets. “Today, we celebrate a … Continue reading “QualityStocksNewsBreaks – Nowigence Inc. (NOWG) Commences Trading on US Mid-Tier Stock Exchange OTCQB”
Nowigence (OTCQB: NOWG) is the software-as-a-service (“SaaS”) technology firm behind Pluaris(TM), a comprehensive and turnkey AI knowledge engine. The company today announced a newly formed independent growth council, comprised of members with diverse fields of expertise, to advise, strategize and assist the operating team with delivery of its growth plan. “We are shifting gears in … Continue reading “QualityStocksNewsBreaks – Nowigence Inc. (NOWG) Forms Independent Council to Drive Growth, Innovation in Machine Learning and Natural Language Processing”
Vision, integrity and critical thinking are key skills for an effective executive team The Nowigence executive team has garnered an estimated 80 years of experience in leading companies around the world Company looking to capitalize on $20-billion-plus market opportunity with Pluaris, its cloud-based knowledge management tool A recent Indeed article noting the top skills of … Continue reading “Nowigence Inc. (NOWG) Executive Team Embodies Key Leadership Skills as Company Introduces Comprehensive AI Management Platform”
Nowigence, an innovative software-as-a-service (“SaaS”) company, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Anoop Bhatia, founder and CEO of Nowigence, joined the latest episode to discuss the company’s business model, its comprehensive AI platform, Pluaris(TM), and the growing opportunity for … Continue reading “QualityStocksNewsBreaks – Nowigence Inc. Featured in Latest Episode of Bell2Bell Podcast”
Nowigence, an innovative software-as-a-service (“SaaS”) company, was featured in a recent episode of “Gamechangers LIVE.” The podcast series shines a spotlight on individuals who are gamechangers in their fields and shares perspective on their journeys, mindsets, struggles and successes in an effort to inspire and inform listeners. Anoop Bhatia, CEO of Nowigence, joined the broadcast, … Continue reading “QualityStocksNewsBreaks – Nowigence Inc. Featured on ‘Gamechangers LIVE’”
Nowigence Inc. is the creator of Pluaris(TM), an off-the shelf, cloud-based, artificial intelligence (“AI”) platform that automates reading and analysis of textual data. Its patentable, proprietary AI technologies automatically read data from hundreds of millions of documents in seconds with human-level comprehension and understanding of text. Even from its early days, Nowigence attracted users from … Continue reading “Nowigence Inc. (NOWG) Is ‘One to Watch’”
Investment Considerations Nowigence Inc. is the creator of Pluaris™, an off-the shelf, cloud-based, artificial intelligence (AI) platform that automates intelligent reading while searching for information in real-time for large datasets. Its patentable, proprietary AI technologies automatically read data from hundreds of millions of documents in seconds with human-level comprehension and understanding of text. Even from … Continue reading “Nowigence Inc. (OTCQB: NOWG)”
The private, plant-based extraction company boasts roster of leaders worth noting CEO served decade-plus in corporate leadership roles across the natural products, agriculture, cannabis sectors Team of qualified experts plus cutting-edge extraction technology means Pure Extracts is set for long-term strategic distribution, product innovation If leaders are, as a Forbes article notes, “the power and … Continue reading “Pure Extract Technologies Inc. Exec Team Offers Decades of Impressive Experience; Represents Power, Intellect Behind Organization”
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that it will be presenting at the upcoming ARM Cell & Gene Therapy Investor Day, hosted by the Alliance for Regenerative Medicine, to be held in New York City on March 21, 2019. Unique to the medical and biotech communities, the investor conference focuses on … Continue reading “QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Present at Seventh Annual ARM Cell & Gene Therapy Investor Day in New York City”
The safety of a novel combined advanced breast cancer treatment has proven to be excellent, BriaCell announced at a major breast cancer conference The monotherapy (i.e. drug on its own) clinical trial showed positive anti-tumor activity in patients with advanced breast cancer and metastases Further information about the efficiency of the Bria-IMT/KEYTRUDA combined treatment will … Continue reading “BriaCell Therapeutics Corp.’s (OTCQB: BCTXF) (TSX.V: BCT) Breast Cancer Treatment Confirms Positive Anti-Tumor Activity”
